CCIA
GOSS icon

Campbell & Co Investment Adviser’s Gossamer Bio GOSS Stock Holding History

Campbell & Co Investment Adviser’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-34,205
Closed -$410K – 860
2022
Q3 		$410K Buy
+34,205
New +$425K 0.09% 377
2022
Q2 		– Sell
-11,442
Closed -$99K – 765
2022
Q1 		$99K Sell
11,442
-7,158
-38% -$69K 0.03% 668
2021
Q4 		$210K Sell
18,600
-1,600
-8% -$19K 0.07% 523
2021
Q3 		$254K Buy
+20,200
New +$186K 0.08% 433

Other funds holding GOSS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Campbell & Co Investment Adviser's GOSS Position: Q4 2022 in Review

Campbell & Co Investment Adviser sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 34,205 shares — an estimated $410K sold.

Campbell & Co Investment Adviser first reported a position in GOSS in Q3 2021 and held it in 4 quarters. The position peaked at $410K in Q3 2022. 120 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

  • Campbell & Co Investment Adviser reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 34,205 Gossamer Bio shares in Q4 2022, an estimated $410K.
  • Campbell & Co Investment Adviser first reported a position in Gossamer Bio in Q3 2021 and held it in 4 quarters.
  • Campbell & Co Investment Adviser's Gossamer Bio position peaked at $410K in Q3 2022.
  • 120 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2022, filed 14 Feb 2023.